![Richard M. Pinnola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard M. Pinnola
Vorstandsvorsitzender bei
NeoDiagnostix, Inc.
Profil
Richard M.
Pinnola is currently the President & Chief Executive Officer at NeoDiagnostix, Inc. He previously held positions as Vice President-Marketing & Commercial Development at Becton, Dickinson & Co., Chief Operating Officer at LipoScience, Inc., and Principal at Roche Molecular Systems, Inc. Pinnola received his undergraduate degree from New York University.
Aktive Positionen von Richard M. Pinnola
| Unternehmen | Position | Beginn |
|---|---|---|
NeoDiagnostix, Inc.
 NeoDiagnostix, Inc. Medical/Nursing ServicesHealth Services Develops molecular diagnostic and prognostic tests for the treatment of cancer | Vorstandsvorsitzender | 16.02.2010 |
Ehemalige bekannte Positionen von Richard M. Pinnola
| Unternehmen | Position | Ende |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Vertrieb & Marketing | - |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Corporate Officer/Principal | - |
| LIPOSCIENCE INC | Geschäftsführer | - |
Ausbildung von Richard M. Pinnola
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Becton, Dickinson & Co.
 Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
LipoScience, Inc.
 LipoScience, Inc. Medical SpecialtiesHealth Technology Operates as an in vitro diagnostic company for cardiovascular and metabolic diseases using technology platform based on nuclear magnetic resonance | Health Technology |
NeoDiagnostix, Inc.
NeoDiagnostix, Inc. Medical/Nursing ServicesHealth Services Develops molecular diagnostic and prognostic tests for the treatment of cancer | Health Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Health Services |
